A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer

NCT01774786 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

780

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: 5-Fluorouracil
DRUG: Capecitabine
DRUG: Cisplatin
DRUG: Pertuzumab
DRUG: Placebo
DRUG: Trastuzumab

Sponsor

Hoffmann-La Roche